Toward an integrated map of genetic interactions in cancer cells
暂无分享,去创建一个
Thomas Hielscher | Benedikt Rauscher | Florian Heigwer | Michael Boutros | Luisa Henkel | Oksana Voloshanenko | M. Boutros | T. Hielscher | Florian Heigwer | Benedikt Rauscher | Luisa Henkel | O. Voloshanenko
[1] N. Dahms,et al. Glucosidase II and MRH-domain containing proteins in the secretory pathway. , 2015, Current protein & peptide science.
[2] Adam P. Rosebrock,et al. A global genetic interaction network maps a wiring diagram of cellular function , 2016, Science.
[3] A. Fukui,et al. Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling , 2015, Molecular and Cellular Biology.
[4] Julio Saez-Rodriguez,et al. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia , 2016, Cell reports.
[5] D. Durocher,et al. Evaluation and Design of Genome-Wide CRISPR / SpCas 9 Knockout Screens , 2017 .
[6] M. Boutros,et al. Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] K. Basler,et al. Porcupine-mediated lipidation is required for Wnt recognition by Wls. , 2012, Developmental biology.
[8] Wolfgang Huber,et al. Mapping of signaling networks through synthetic genetic interaction analysis by RNAi , 2011, Nature Methods.
[9] D. Durocher,et al. Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens , 2017, G3: Genes, Genomes, Genetics.
[10] S. Scholpp,et al. Tyrosine phosphorylation of LRP6 by Src and Fer inhibits Wnt/β‐catenin signalling , 2014, EMBO reports.
[11] Jan Winter,et al. CRISPR library designer (CLD): software for multispecies design of single guide RNA libraries , 2016, Genome Biology.
[12] B. Garvik,et al. Principles for the Buffering of Genetic Variation , 2001, Science.
[13] L. Hartwell,et al. Integrating genetic approaches into the discovery of anticancer drugs. , 1997, Science.
[14] D. Sidransky,et al. Role of the p16 tumor suppressor gene in cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[16] P. Phillips. Epistasis — the essential role of gene interactions in the structure and evolution of genetic systems , 2008, Nature Reviews Genetics.
[17] Michael Boutros,et al. Regulation of Wnt protein secretion and its role in gradient formation , 2008, EMBO reports.
[18] G. Casari,et al. A reversible gene trap collection empowers haploid genetics in human cells , 2013, Nature Methods.
[19] S. Grossman,et al. Mechanisms of mutant p53 stabilization in cancer. , 2014, Sub-cellular biochemistry.
[20] R. DePinho,et al. Collateral Lethality: A new therapeutic strategy in oncology. , 2015, Trends in cancer.
[21] Julio Collado-Vides,et al. BClass: A Bayesian Approach Based on Mixture Models for Clustering and Classification of Heterogeneous Biological Data , 2004 .
[22] R. Sakthivel,et al. Exploring preferred amino acid mutations in cancer genes: Applications to identify potential drug targets. , 2016, Biochimica et biophysica acta.
[23] Judith B. Zaugg,et al. Data-driven hypothesis weighting increases detection power in genome-scale multiple testing , 2016, Nature Methods.
[24] Per B. Brockhoff,et al. lmerTest Package: Tests in Linear Mixed Effects Models , 2017 .
[25] V. Rotter,et al. Mutant p53 gain-of-function in cancer. , 2010, Cold Spring Harbor perspectives in biology.
[26] Michael Boutros,et al. Secretion of Wnt Ligands Requires Evi, a Conserved Transmembrane Protein , 2006, Cell.
[27] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[28] A. Bergman,et al. Evolutionary capacitance as a general feature of complex gene networks , 2003, Nature.
[29] Brock F. Binkowski,et al. Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate , 2012, ACS chemical biology.
[30] Ralf Herwig,et al. The ConsensusPathDB interaction database: 2013 update , 2012, Nucleic Acids Res..
[31] Antoine de Weck,et al. Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening , 2017, Cell.
[32] T. Golub,et al. Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting. , 2016, Cancer discovery.
[33] Gary D Bader,et al. Quantitative analysis of fitness and genetic interactions in yeast on a genome scale , 2010, Nature Methods.
[34] M. Boutros,et al. A map of directional genetic interactions in a metazoan cell , 2015, eLife.
[35] Pat Levitt,et al. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse , 2001, Trends in Neurosciences.
[36] E. Lander,et al. Identification and characterization of essential genes in the human genome , 2015, Science.
[37] W. de Lau,et al. The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength , 2014, Genes & development.
[38] Marketa Zvelebil,et al. High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing , 2011, Genome Biology.
[39] Lei S. Qi,et al. Genetic interaction mapping in mammalian cells using CRISPR interference , 2017, Nature Methods.
[40] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[41] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[42] D. Durocher,et al. High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.
[43] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[44] D. Morgens,et al. Systematic comparison of CRISPR-Cas9 and RNAi screens for essential genes , 2016, Nature Biotechnology.
[45] Kristian Cibulskis,et al. RNF43 is frequently mutated in colorectal and endometrial cancers , 2014, Nature Genetics.
[46] D. Bates,et al. Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.
[47] K. Basler,et al. Wntless, a Conserved Membrane Protein Dedicated to the Secretion of Wnt Proteins from Signaling Cells , 2006, Cell.
[48] G. Traver Hart,et al. BAGEL: a computational framework for identifying essential genes from pooled library screens , 2015, BMC Bioinformatics.
[49] Joshua M. Korn,et al. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions. , 2016, Cancer discovery.
[50] C. Bradshaw,et al. Strength of evidence for density dependence in abundance time series of 1198 species. , 2006, Ecology.
[51] M. Waterman,et al. A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities. , 2012, Differentiation; research in biological diversity.
[52] Meagan E. Sullender,et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.
[53] Mingming Jia,et al. COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..
[54] S. Ormanns,et al. WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling , 2014, Oncotarget.
[55] Emanuel J. V. Gonçalves,et al. A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.
[56] Jing-he Li,et al. SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer , 2016, Cancer investigation.
[57] L. Trusolino,et al. Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils , 2011, EMBO molecular medicine.
[58] M. Carl,et al. RAB8B is required for activity and caveolar endocytosis of LRP6. , 2013, Cell reports.
[59] T. Smart,et al. HEK293 cell line: a vehicle for the expression of recombinant proteins. , 2005, Journal of pharmacological and toxicological methods.
[60] Ji Luo,et al. Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction , 2009, Cell.
[61] Paul Polakis,et al. Wnt signaling in cancer. , 2012, Cold Spring Harbor perspectives in biology.
[62] Gary D Bader,et al. Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants , 2001, Science.
[63] T. Ideker,et al. Systematic interpretation of genetic interactions using protein networks , 2005, Nature Biotechnology.
[64] Thomas D. Wu,et al. A comprehensive transcriptional portrait of human cancer cell lines , 2014, Nature Biotechnology.
[65] Aaron N. Chang,et al. Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions , 2017, Nature Methods.
[66] Anastasia Baryshnikova,et al. Exploratory Analysis of Biological Networks through Visualization, Clustering, and Functional Annotation in Cytoscape. , 2016, Cold Spring Harbor protocols.
[67] R. Punnett,et al. The Genetical Theory of Natural Selection , 1930, Nature.
[68] Chengchao Xu,et al. Glycosylation-directed quality control of protein folding , 2015, Nature Reviews Molecular Cell Biology.
[69] W. Kaelin. The Concept of Synthetic Lethality in the Context of Anticancer Therapy , 2005, Nature Reviews Cancer.
[70] Trey Ideker,et al. A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. , 2016, Molecular cell.
[71] R. Barrangou. Cas9 Targeting and the CRISPR Revolution , 2014, Science.
[72] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[73] N. Gueven,et al. The complexity of p53 stabilization and activation , 2006, Cell Death and Differentiation.
[74] Huiming Ding,et al. The synthetic genetic interaction spectrum of essential genes , 2005, Nature Genetics.
[75] Lucas Pelkmans,et al. Predicting functional gene interactions with the hierarchical interaction score , 2013, Nature Methods.
[76] Feng Cong,et al. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma , 2013, Proceedings of the National Academy of Sciences.
[77] Neville E. Sanjana,et al. High-throughput functional genomics using CRISPR–Cas9 , 2015, Nature Reviews Genetics.
[78] Michael Boutros,et al. Towards a compendium of essential genes – From model organisms to synthetic lethality in cancer cells , 2015, Critical reviews in biochemistry and molecular biology.
[79] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[80] Martin Kampmann,et al. Integrated platform for genome-wide screening and construction of high-density genetic interaction maps in mammalian cells , 2013, Proceedings of the National Academy of Sciences.
[81] R. Bernards,et al. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.
[82] Hans-Werner Mewes,et al. CORUM: the comprehensive resource of mammalian protein complexes , 2007, Nucleic Acids Res..
[83] Joshua M. Stuart,et al. A global analysis of genetic interactions in Caenorhabditis elegans , 2007, Journal of biology.
[84] Eric S. Lander,et al. Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras , 2017, Cell.
[85] Michael Boutros,et al. The art and design of genetic screens: RNA interference , 2008, Nature Reviews Genetics.
[86] P. Yaswen,et al. A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells , 2009, PloS one.
[87] S. Elledge,et al. A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. , 2017, Cell reports.
[88] Robert P. St.Onge,et al. Defining genetic interaction , 2008, Proceedings of the National Academy of Sciences.
[89] A. Joe,et al. Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy , 2006, Nature Clinical Practice Oncology.
[90] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[91] Hans Clevers,et al. Wnt/β-Catenin Signaling and Disease , 2012, Cell.
[92] Hans Clevers,et al. Genome-wide CRISPR screens reveal a Wnt–FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors , 2016, Nature Medicine.
[93] M. Boutros,et al. A Genome-Wide RNA Interference Screen Identifies Caspase 4 as a Factor Required for Tumor Necrosis Factor Alpha Signaling , 2012, Molecular and Cellular Biology.
[94] J. Doudna,et al. The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.
[95] T. Belenkaya,et al. Roles of N-glycosylation and lipidation in Wg secretion and signaling. , 2012, Developmental biology.
[96] E. Lander,et al. Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.
[97] E. Krebs,et al. The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[98] A. Berns,et al. Drugging the addict: non‐oncogene addiction as a target for cancer therapy , 2016, EMBO reports.
[99] Andrew E. Jaffe,et al. Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .
[100] Jan Winter,et al. GenomeCRISPR - a database for high-throughput CRISPR/Cas9 screens , 2016, Nucleic Acids Res..
[101] R. Fisher. Secrets of a double agent: CDK7 in cell-cycle control and transcription , 2005, Journal of Cell Science.
[102] S. Nijman. Synthetic lethality: General principles, utility and detection using genetic screens in human cells , 2011, FEBS letters.
[103] M. Raaben,et al. Genetic wiring maps of single-cell protein states reveal an off-switch for GPCR signalling , 2017, Nature.
[104] Max A. Horlbeck,et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation , 2016, eLife.
[105] Hideki Yamamoto,et al. Glycosylation and palmitoylation of Wnt‐3a are coupled to produce an active form of Wnt‐3a , 2007, Genes to cells : devoted to molecular & cellular mechanisms.
[106] R. Bernards,et al. CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes , 2016, Nature Biotechnology.
[107] Calvin B. Bridges,et al. The Origin of Variations in Sexual and Sex-Limited Characters , 1922, The American Naturalist.
[108] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[109] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[110] Gary D Bader,et al. The Genetic Landscape of a Cell , 2010, Science.
[111] Thomas Lengauer,et al. ROCR: visualizing classifier performance in R , 2005, Bioinform..
[112] Wolfgang Huber,et al. Mapping genetic interactions in human cancer cells with RNAi and multiparametric phenotyping , 2013, Nature Methods.
[113] Xi He,et al. Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.
[114] A. McMahon,et al. Wnt family proteins are secreted and associated with the cell surface. , 1993, Molecular biology of the cell.